Abtak Logo

generic-drug News

Stay updated with the latest generic-drug news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on generic-drug topics.

fallback-img
soure image
14
BusinessJul 04, 2025 11:50 AM

Alembic Pharmaceuticals acquires Utility Therapeutics for $12 million to strengthen U.S. footprint -...

Bengaluru: Alembic Pharmaceuticals, Inc., the U.S. subsidiary of Alembic Pharmaceuticals Ltd., has acquired Utility Therapeutics Ltd. ("Utility") in a $12 million deal to strengthen its presence in the U.S. market. Alembic will begin the commercialization of Utility's recently FDA approved product Pivya® (pivmethecillam) for the treatment of uncomplicated urinary tract infections. Pivya® was approved by the FDA in April 2024. Commenting on the acquisition, Mr. Pranav Amin, Managing Director of ...Read More >

LatestLY - Business - News Image
soure image
15
BusinessJul 03, 2025 10:38 AM

Latest News | Alembic Acquires Utility Therapeutics for USD 12 Mn | LatestLY

New Delhi, Jul 3 (PTI) Alembic Pharmaceuticals on Thursday said its US arm has acquired Utility Therapeutics Ltd in a USD 12 million (over Rs 100 crore) deal to strengthen its presence in the American market. The acquisition is being done by Alembic Pharmaceuticals, Inc, the company's US subsidiary, Alembic said in a statement. Also Read | Kolkata Fatafat Result Today: Kolkata FF Result for July 03, 2025 Declared, Check Winning Numbers and Result Chart of Satta Matka-Type Lottery Game. Subseq ...Read More >

CTN News l Chiang Rai Times - Business - News Image
soure image
13
BusinessJul 02, 2025 09:07 AM

Pharmaceutical Factory Blast In Southern India Leaves Dozens Dead

NEW DELHI - Dozens have died in a major explosion at Sigachi Industries Pvt. Ltd., a pharmaceutical manufacturing plant in Pashamylaram, Sangareddy, Telangana, India. The blast, which happened at around 9:10 a.m. on Monday, 30 June 2025, has become one of the state's deadliest industrial disasters. At least 44 workers lost their lives, and many more suffered serious injuries. As of Wednesday, 2 July, search teams are still looking for 12 missing workers, and there are concerns that the number o ...Read More >

The Manila times - Business - News Image
soure image
28
BusinessJul 01, 2025 02:39 PM

Death toll rises to 36 after explosion at a pharmaceutical factory in southern India

HYDERABAD, India -- The death toll from Monday's massive explosion and fire at a pharmaceutical factory in India's southern state of Telangana has risen to at least 36 while about three dozen were left injured, authorities said Tuesday. The fire department recovered the charred bodies of 34 workers from the accident site in an industrial area about 50 kilometers (31 miles) from the state capital Hyderabad, the state's fire services director G.V. Narayana Rao told The Associated Press. Two othe ...Read More >

Daily Mail Online - Health - News Image
soure image
8
HealthJul 01, 2025 11:19 AM

Death toll rises to 36 following an explosion and fire at a...

HYDERABAD, India (AP) - The death toll from Monday's massive explosion and fire at a pharmaceutical factory in India´s southern state of Telangana has risen to at least 36 while about three dozen were left injured, authorities said Tuesday. The fire department recovered the charred bodies of 34 workers from the accident site in an industrial area about 50 kilometers (31 miles) from the state capital Hyderabad, the state´s fire services director G.V. Narayana Rao told The Associated Press. Two ...Read More >

Economic Times - Business - News Image
soure image
29
BusinessJun 05, 2025 10:02 PM

Dr Reddy's, Alvotech to co-develop Keytruda biosimilar

Mumbai: Dr Reddy's Laboratories has entered into a collaboration with Reykjavik, Ireland-based biotech company Alvotech to co-develop, manufacture and commercialise a biosimilar version of blockbuster cancer drug Keytruda for the global markets. Keytruda (generic name is pembrolizumab), manufactured and marketed by Merck & Co, is the most successful medicine, recording worldwide sales of $29.5 billion in 2024. It is used to treat multiple forms of cancer. Under the terms of the agreement, both ...Read More >

NewsDrum - Business - News Image
soure image
34
BusinessDec 17, 2024 04:02 PM

Granules India gets USFDA nod for generic drug

New Delhi, Dec 17 (PTI) Drug firm Granules India on Tuesday said its subsidiary has received approval from the US health regulator for a generic medication used to treat attention-deficit hyperactivity disorder. Granules Pharmaceuticals, Inc (GPI) has received approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Lisdexamfetamine Dimesylate chewable tablets, the drug firm said in a statement. The approved drug is available in multiple stren ...Read More >

Devdiscourse - Other - News Image
soure image
39
OtherNov 26, 2024 12:23 PM

India's Pharmaceutical Prowess: Leading the Global Generic Drug Market | Business

India's pharmaceutical industry, valued at $50 billion, is booming as a global leader in generic drugs. With significant exports to 200+ countries, India meets a substantial portion of global demand for affordable medicine. Challenges include regulatory hurdles and quality assurance, as the nation aims to expand its generic drug market. The Indian pharmaceutical industry, currently valued at $50 billion, is playing an increasingly crucial role on the global stage. Renowned as the 'pharmacy of t ...Read More >

Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.